• SENSEX 81,463.09
    -721.08 (--0.88%)
  • BANKNIFTY 56,528.90
    -537.15 (--0.94%)
  • Authum Invest
    2,250.00 985.45(%)
  • Indian Energy Ex
    149.45 244.35(%)
  • Vimta Labs
    598.90 598.90(%)
  • Bharti Airtel
    1,952.40 2,045.50(%)
  • Force Motors
    16,488.00 6,128.55(%)
  • Bajaj Finance
    897.65 642.61(%)
  • Anant Raj
    606.00 947.25(%)
  • Jayaswal Neco
    40.05 26.06(%)
  • Sharda Cropchem
    1,090.25 1,090.25(%)
  • Infosys
    1,511.35 1,307.10(%)
  • Olectra Greentec
    1,460.00 973.65(%)
  • Tata Motors
    685.00 542.55(%)
  • Eternal Ltd
    306.25 189.60(%)
  • Trent
    5,033.80 4,491.75(%)
  • Reliance Industr
    1,384.50 1,115.55(%)
  • Waaree Energies
    3,171.00 1,808.65(%)
  • Phoenix Mills
    1,545.00 1,965.00(%)
  • Kajaria Ceramics
    1,151.00 745.00(%)
  • Adani Green
    972.75 758.00(%)
  • Cipla
    1,553.00 1,702.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Abbott India Ltd Pharmaceuticals - Multinational

  • MNC Asc-Abbott
  • BSE Code : 90.0
  • ISIN : INE358A01014
33,780.00 -800 (-2.31%)
  • As on 26 Jul 2025 (EOD)
  • Today’s Low

    33,545.00
  • Today’s High

    34,290.00
  • Open

    34,175.00
  • Perv Close

    34,580.00
  • 52W Low

    25,325.00
  • 52W High

    37,000.00

Key Indicators

  • P/E(TTM)

    50.72

  • Mar.Cap (₹Cr.)

    71,782.50

  • Div & Yield %

    1.41

  • Book Value(₹)

    1,992.07

  • Debt-Equity Ratio

    -2.31

  • AGM Date

    25-Jul-2025

  • EPS

    665.85

  • P/E Ratio

    50.72

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    71,782.50

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    21.25

  • BV (₹)

    1,992.10

  • Sales( ₹ in Cr.)

    6,445.79

  • NP (in Cr.)

    1,414.92

  • NP Var(%)

    18.0

  • Div%

    4750.0

  • CPS (₹)

    699.60

  • EPS (₹)

    665.80

  • Traded Value (₹ in Lakhs)

    71,763.80

  • 52 Week High

    37,000.00

  • 52 Week Low

    25,325.00

  • Price BSE

    33771.0

  • Price NSE

    33,780.00

  • Market Capital( in Cr.)

    71,763.80

  • P/C Ratio

    48.30

  • P/E Ratio

    50.70

  • Price Vs.BV

    665.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 6,445.79 5,875.26 5,379.08 4,932.57 4,310.02 4,093.14
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 6,445.79 5,875.26 5,379.08 4,932.57 4,310.02 4,093.14
Other Income 275.58 248.27 154.15 83.16 80.90 114.39
Stock Adjustments 180.68 -7.73 -66.09 22.28 104.00 -61.24
Total Income 6,902.05 6,115.80 5,467.14 5,038.01 4,494.92 4,146.29
EXPENDITURE :            
Raw Materials 3,677.46 3,212.88 2,908.97 2,679.49 2,494.92 2,254.39
Power and Fuel Cost 15.43 16.63 17.15 14.98 12.74 13.73
Employee Cost 587.54 576.58 563.59 579.46 492.65 476.11
Other Manufacturing Expenses 134.09 126.47 79.99 59.82 49.66 49.84
Selling and Administration Expenses 448.84 429.89 467.74 459.18 366.98 400.27
Miscellaneous Expenses 68.51 51.98 69.92 80.15 75.61 81.11
Employee Benefit Expenses 587.54 576.58 563.59 579.46 492.65 476.11
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 4,931.87 4,414.43 4,107.36 3,873.08 3,492.56 3,275.45
Operating Profit 1,970.18 1,701.37 1,359.78 1,164.93 1,002.36 870.84
Interest 11.43 12.45 15.99 19.10 18.28 8.53
Gross Profit 1,958.75 1,688.92 1,343.79 1,145.83 984.08 862.31
Depreciation 71.80 71.17 69.97 66.10 58.13 59.61
Profit Before Tax 1,886.95 1,617.75 1,273.82 1,079.73 925.95 802.70
Current Tax 469.79 415.46 325.60 281.16 239.05 208.29
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 2.72 1.07 -1.19 -0.13 -3.79 1.48
Reported Net Profit 1,414.44 1,201.22 949.41 798.70 690.69 592.93
Extraordinary Items -0.48 0.12 -0.19 0.00 -0.18 -0.41
Adjusted Net Profit 1,414.92 1,201.10 949.60 798.70 690.87 593.34
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 -35.51
P & L Balance brought forward 2,819.01 2,428.51 2,158.40 2,023.93 1,933.54 1,573.53
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 1,012.67 810.72 679.30 664.23 600.30 197.41
P & L Balance carried down 3,220.78 2,819.01 2,428.51 2,158.40 2,023.93 1,933.54
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 4,750.00 4,100.00 3,250.00 2,750.00 2,750.00 2,500.00
Dividend Per Share(Rs) 475.00 410.00 325.00 275.00 275.00 250.00
Earnings Per Share-Unit Curr 665.62 565.28 446.78 375.86 325.03 279.03
Earnings Per Share(Adj)-Unit Curr 665.62 565.28 446.78 375.86 325.03 279.03
Book Value 1,992.07 1,740.65 1,500.49 1,326.96 1,224.55 1,144.33
Book Value(Adj)-Unit Curr 1,992.07 1,740.65 1,500.49 1,326.96 1,224.55 1,144.33

Shareholding Pattern

  • Promoter Group

    74.99%

  • Public Share Holding

    25.01%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 15,934,048 74.99 15,934,048 3
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 15,934,048 74.99 15,934,048 3
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 0 0.00 0 0
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 4,819 0.02 4,561 4
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 34,602 0.16 34,602 12
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 239,714 1.13 239,714 18
Mutual Funds / UTI 1,651,415 7.77 1,651,365 35
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 56,189 0.26 56,189 13
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 1,986,739 9.35 1,986,431 82
2] Non Institution
Bodies Corporate 152,938 0.72 152,848 921
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 150,976 0.71 149,049 1,442
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 21,242 0.10 21,242 1
Individuals holding nominal share capital up to Rs. 1 lakh 2,815,516 13.25 2,647,698 63,561
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 187,843 0.88 187,843 1,574
Sub Total 3,328,515 15.66 3,158,680 67,499
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 21,249,302 100.00 21,079,159 67,584

Company Background

Abbott India LtdPharmaceuticals - Multinational

  • Abbott India Ltd
  • BSE Code : 90.0
  • ISIN : INE358A01014
  • Incorporation Year

    1944

  • Registered Office

    Unit No 3 Corporate Park
    Sion Trombay Road Chembur, Mumbai,
    Maharashtra-400071

  • Telephone

    91-22-67978888/50461000/2000/1119

  • FAX

    91-22-50169400

  • Chairman

    Munir Shaikh

  • Managing Director

    Kartik Rajendran

  • Company Secretary

    Sangeeta Shetty

  • Auditor

    Walker Chandiok & Co LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Abbott India Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Abbott India 33,771.20 6,684.73 6,409.15 50.74 44.95
Astrazeneca Phar 8,832.65 1,756.92 1,716.29 190.77 32.94
P & G Health Ltd 5,831.90 1,166.89 1,151.26 38.54 39.76
Glaxosmi. Pharma 3,154.75 3,866.05 3,723.49 58.15 58.72
Cipla 1,531.10 20,029.57 19,044.85 23.98 21.40
Novartis India 1,018.80 398.23 356.27 24.93 16.64
Amrutanjan Healt 679.00 437.58 421.23 38.62 20.84
Fermenta Biotec. 375.35 442.21 430.53 16.34 17.61
Guj. Themis Bio. 363.35 174.19 169.82 81.10 44.82
Bliss GVS Pharma 153.45 703.42 667.20 23.46 9.16
Ambalal Sarabhai 32.88 19.33 4.04 30.44 2.10